News tagged with patent
You don't 'own' your own genes: Researchers raise alarm about loss of individual 'genomic liberty' due to gene patents
Humans don't "own" their own genes, the cellular chemicals that define who they are and what diseases they might be at risk for. Through more than 40,000 patents on DNA molecules, companies have essentially ...
Genetics Mar 26, 2013 | 4.8 / 5 (20) | 17 |
(Medical Xpress) -- Yale researcher Jose Cordova and Erich Astudillo from the University of Chile (and Founder of Top Tech Innovations SpA) have after working together, discovered a new molecule that kills the bacteria Streptococcus Mu ...
Dentistry Jul 10, 2012 | 4.5 / 5 (10) | 13 |
Just like the old Crystal Gayle song, a new laser technology could soon allow you to turn those boring brown eyes of your to a rich and beautiful blue. But you better make sure that blue eyes are what you really want because ...
Other Nov 04, 2011 | 4 / 5 (11) | 21 |
(Medical Xpress)—On April 15, the Supreme Court will hear oral argument in Association for Molecular Pathology v. Myriad Genetics, a case that could answer the question, "Under what conditions, if any, ...
Genetics Apr 11, 2013 | 4.3 / 5 (6) | 16 |
Supply of cheap, copycat drugs for the developing world could be badly threatened if Swiss firm Novartis wins a challenge to India's patent law, medical charity MSF said on Monday.
Medications Sep 05, 2011 | 5 / 5 (4) | 1
(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.
Medications Mar 12, 2012 | 5 / 5 (4) | 0
Indian generics giant Cipla says it has scored a "landmark" court win in a patent challenge launched by Switzerland's Roche Holding over the Mumbai firm's version of a lung-cancer drug.
Medications Sep 08, 2012 | 5 / 5 (4) | 2
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting ...
Medications Mar 05, 2013 | 5 / 5 (4) | 3
A federal appeals court on Friday ruled in favor of Myriad Genetics after a legal battle over whether the US company could keep its patent on genes linked to an inherited form of breast cancer.
Cancer Jul 30, 2011 | 5 / 5 (3) | 1
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world ...
Medications Apr 01, 2013 | 5 / 5 (3) | 0
Researchers at Albert Einstein College of Medicine of Yeshiva University and the Icahn School of Medicine at Mount Sinai have found that macrophages – white blood cells that play a key role in the immune response – also ...
Medical research Mar 17, 2013 | 4.7 / 5 (3) | 1 |
The American Civil Liberties Union and the Public Patent Foundation have petitioned the U.S. Supreme Court to hear Association for Molecular Pathology v. U.S. Patent and Trademark Office, a case that challenges the validity ...
Other Dec 15, 2011 | 5 / 5 (2) | 0
AMP presented testimony to the Patent and Trademark Office requesting moratorium on human gene patenting
Today, the Association for Molecular Pathology (AMP) asked the U.S. Patent and Trademark Office (USPTO) to place a moratorium on the issuing of patents on human genes during testimony presented at an Agency hearing on genetic ...
Genetics Feb 16, 2012 | 5 / 5 (2) | 0
University of Texas at Arlington researchers have obtained a patent for a device aimed at saving babies lives through improved and rapid detection of Sudden Infant Death Syndrome.
Pediatrics May 09, 2012 | 5 / 5 (2) | 0
For centuries, Indian housewives have used homemade remedies based on cow's milk to cure constipation—but in 2009 Swiss giant Nestle applied for a patent to protect a similar product of its own.
Medications Oct 14, 2012 | 5 / 5 (2) | 0
A patent is a set of exclusive rights granted by a state to an inventor or his assignee for a limited period of time in exchange for a disclosure of an invention.
The procedure for granting patents, the requirements placed on the patentee and the extent of the exclusive rights vary widely between countries according to national laws and international agreements. Typically, however, a patent application must include one or more claims defining the invention which must be new, inventive, and useful or industrially applicable. In many countries, certain subject areas are excluded from patents, such as business methods and mental acts. The exclusive right granted to a patentee in most countries is the right to prevent others from making, using, selling, or distributing the patented invention without permission.
Under the World Trade Organization's (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights, patents should be available in WTO member states for any inventions, in all fields of technology, and the term of protection available should be minimum twenty years. Different types of patents may have varying patent terms (i.e., durations).
For more information about Patent, read the full article at
This text uses material from Wikipedia and is available under the GNU Free Documentation License.